This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Comparison of Ultrafast Echo With Echotracking

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
French Cardiology Society
ClinicalTrials.gov Identifier:
NCT01743352
First received: December 4, 2012
Last updated: October 1, 2015
Last verified: October 2015
  Purpose
The aim is to compare a new technique for assessing mechanical properties of large arteries: the Ultrafast echo with the reference technique, the echotracking. This will be done by studying in parallel hypertensive patients and controls with both techniques and this will revisit old concepts of increased stiffness in hypertensive arteries.

Condition
Essential Untreated Hypertension Healthy Volunteers

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Protocole ULTRAFAST - ECHOTRACKING : Remodelage pariétal et rigidité artérielle Chez l'Hypertendu : Nouvelle étude de Leur Relation Utilisant l'élastographie Par Ultrafast-écho et la séparation Intima/média Par écho-tracking

Further study details as provided by French Cardiology Society:

Primary Outcome Measures:
  • Local common carotid artery pulse wave velocity [ Time Frame: Day 1 ]

Secondary Outcome Measures:
  • Common carotid artery Young's modulus (Stiffness of wall material) [ Time Frame: Day 1 ]

Enrollment: 57
Study Start Date: March 2013
Study Completion Date: August 2015
Primary Completion Date: March 2015 (Final data collection date for primary outcome measure)
Groups/Cohorts
Hypertension patients
Local common carotid artery pulse wave velocity is compared in patients with hypertension and healthy volunteers.
Healthy Volunteers
Local common carotid artery pulse wave velocity is compared in hypertension patients and healthy volunteers

Detailed Description:

Ultrafast ECHO is a new non invasive method for assessing stiffness of living tissues. It takes advantage of very fast imaging technologies (up to 20 000 images/sec) to measure the diffusion of pressure waves in the tissues. This pressure wave can be either natural (blood pressure), or generated by an very short ultrasonic impulsion at a given place. By using both modes, it is possible to have a precise cartography of tissue mechanical properties. This technique is applied to solid tissues such as breast or liver, but not yet currently to hollow tissues such as arteries. The aim of the present study is to compare the values of stiffness obtained with Ultrafast ECHO with the reference non invasive technique, the Echotracking, which measures stiffness by assessing the deformation of arteries in response to changes in blood pressure. On the physiological part, we will revisit old concepts of increased stiffness of hypertensive's arteries. Indeed, hypertension is associated with increased stiffness due to recruitement of collagen fibers, but also to chronic remodelling. We have shown before that this remodelling conducts to accumulation of arterial tissue of lesser intrinsic stiffness. The latter finding was done through models based on echotracking measurements. It will be interesting to see whether it holds true when stiffness is directly measured.

Sixty subjects (30 normotensive and30 hypertensives) will be included and studied once. Measurement will be performed in random order 3 time on the common carotid artery on both sides. Aortic stiffness will be measured by pulse wave velocity

  Eligibility

Ages Eligible for Study:   25 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Patients presenting Essential untreated hypertension Healthy Volunteers
Criteria

Inclusion Criteria:

  • hypertension,
  • essential (WHO workup),
  • untreated (> 28 days of treatment interruption, < 6 months of treatment) on insufficiently equilibrated (BP > 140 and/or 90 mmHg)

Exclusion Criteria:

  • Any concomitant severe disease compromising patient's participation or compliance
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01743352

Locations
France
Hopital Européen Georges Pompidou / Service de Pharmacologie
Paris, France, 75015
Sponsors and Collaborators
French Cardiology Society
Investigators
Principal Investigator: Stéphane Laurent, MD, PhD Pharmacology Department - Hopital Européen Georges Pompidou - Paris
  More Information

Responsible Party: French Cardiology Society
ClinicalTrials.gov Identifier: NCT01743352     History of Changes
Other Study ID Numbers: 2012-01
ID - RCB 2012-A01255-38 ( Other Identifier: ANSM )
Study First Received: December 4, 2012
Last Updated: October 1, 2015

Keywords provided by French Cardiology Society:
Large arteries
stiffness
intima media thickness
ultrasound imaging

ClinicalTrials.gov processed this record on June 23, 2017